Antibody for the treatment of myocardial infarction

The present invention relates to a method for treating MI or AMI in a subject in need thereof comprising a step of administering to said subject a therapeutically effective amount of an agent capable of depleting CD8 T cells. More particularly, this present invention relates to a method for treating acute myocardial infarction by reducing the size of necrosis and limiting the post ischemic left ventricular remodeling.

Keywords: Cardiovascular, Myocardial infarction, antibody, Cardio-Immunology
Patent Application number: EP15 306 612.1
Inventors:
Hafid AIT-OUFELLA
Publications:
In progress

Reference:

BIO15275-T1

Business Developper
contact
Aymeric Empereur
Aymeric Empereur
Business Developer
Patent filling date: 2015-10-12

You might also be interested in